Skip to content
Health Policy Watch
  • Home
  • About Us
X Instagram LinkedIn Facebook Bluesky
Donate
  • Antimicrobial Resistance
  • Infectious Diseases
  • Pandemics & Emergencies
  • Non-Communicable Diseases
  • Health, Climate & SDGs
Newsletter
X Instagram LinkedIn Facebook Bluesky
Donate
Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars?
10/05/2017 Tatum Anderson
The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars. Continue reading ->

Posts navigation

Newer posts
Sign up for free news alerts
Signup Link
Contact Us
[email protected]
1-5 Route des Morillions CP 2100
Geneva 1211, Switzerland
+41 22 791 67 28
Donate
About
Privacy Policy
Archives
Staff Access
Log in
Entries RSS
Comments RSS
Wordpress.org
Supported by
Sponsors
Wellcome
CeHDI
Geneva
Loro
Copyright © 2026 Global Policy Reporting